Exploring adolescent experiences with psychotropic drugs for anorexia
Subjective Experience of Psychotropic Drugs Among Adolescents (Their Parents and Professionals) With Anorexia Nervosa
This study is trying to understand how teenagers with anorexia and their families feel about using certain medications to help with their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 90 (estimated) |
| Ages | 12 Years and up |
| Sex | All |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris, IDF) |
| Trial ID | NCT06211517 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather insights from adolescents with anorexia nervosa, their parents, and healthcare professionals regarding the use of psychotropic medications. Through semi-structured interviews, the study will explore participants' perceptions and experiences related to antidepressants and atypical antipsychotics. The research seeks to understand the complexities of these experiences, including initial reactions to medication proposals and the perceived effects of these drugs. By focusing on qualitative data, the study aims to provide a nuanced understanding of the role of psychotropic drugs in the treatment of anorexia nervosa in adolescents.
Who should consider this trial
Good fit: Ideal candidates include adolescents aged 12 to 25 diagnosed with anorexia nervosa who have received psychotropic medications.
Not a fit: Patients with atypical eating disorders not meeting DSM-5 criteria for anorexia nervosa or those with a BMI below 15 may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of how psychotropic drugs affect adolescents with anorexia, potentially leading to improved treatment approaches.
How similar studies have performed: While qualitative studies on psychotropic drug experiences in adolescents with anorexia are limited, previous research has indicated the importance of understanding patient perspectives in treatment.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Adolescents : * Aged 12 to 25 years * Suffering from anorexia nervosa (restrictive or mixed) according to DSM-5 (Diagnostic and Statistical Manual) criteria * Received psychotropic drugs (antidepressant treatment and/or APA) during their care, either ongoing or discontinued before this study started Parents of adolescents suffering from anorexia nervosa for whom a psychotropic drug has been prescribed and whose adolescents meet inclusion criteria Healthcare Professionals working with adolescents suffering from eating disorders Exclusion Criteria: Adolescents : * Atypical eating disorder that does not meet the DSM-5 criteria for restrictive or mixed anorexia nervosa * BMI\<15 * Prescription of an antidepressant other than an SSRI (Selective Serotonin Reuptake Inhibitor) * Prescription of an APA for the indication of psychotic symptoms
Where this trial is running
Paris, IDF
- Maison de Solenn Maison des Adolescents, Cochin Hospital — Paris, Idf, France (Recruiting)
Study contacts
- Principal investigator: Maude Ludot-Gregoire, MD — Cochin Hospital (maison de Solenn)
- Study coordinator: Maude Ludot-Gregoire, MD, psychiatrist
- Email: maude.ludot@aphp.fr
- Phone: 00 33 1 58 41 28 41
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.